Supriya Lifescience Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
753.00 +27.40 (3.78%)Updated : 22 Jan 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -0.11-16.98-4.95-49.37
Net Changein Cash 4.20-82.63-70.33138.63
Cash Taxes Paid 59.1837.6428.8660.96
Net Income/ Starting Line 248.48165.69123.49207.24
Total Cash Dividends Paid -6.44-4.83-4.83-4.39
Changesin Working Capital -97.54-54.79-64.50-165.65
Cashfrom Operating Activities 164.68113.3166.1948.80
Cash Interest Paid 1.690.553.083.99
Cashfrom Financing Activities -8.23-22.36-3.37149.65
Issuance( Retirement)of Stock Net 0.000.000.00200.00
Depreciation/ Depletion 20.4415.8111.8110.12
Other Investing Cash Flow Items Total 10.13-27.92-24.700.08
Capital Expenditures -162.38-145.66-108.44-59.90
period Type ----
Non- Cash Items -6.71-13.41-4.61-2.91
Financing Cash Flow Items -1.69-0.556.413.41
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -152.24-173.58-133.15-59.82
*All figures in crores except per share values
Recommended For You
Trending Stocks
189.20+4.85(2.63%)
276.50-6.90 (-2.43%)
4,024.00-56.20 (-1.38%)